Gyeongnam Pharmaceutical Healthcare Designated as a Non-Compliant Disclosure Corporation

[Asia Economy Reporter Han Jinju] The Korea Exchange KOSDAQ Market Division announced on the 20th that it will designate Gyeongnam Pharmaceutical Healthcare as a non-compliant disclosure corporation due to the reversal of a disclosure related to the termination of a single sales and supply contract.

The designation as a non-compliant disclosure corporation will take effect on the 21st. The penalty points imposed are 6 points, and Gyeongnam Pharmaceutical's total penalty points for non-compliant disclosure corporations over the past year (including the current penalty points) amount to 64.8 points.